Cargando…

Cross reactivity of serological response to SARS-CoV-2 vaccination with viral variants of concern detected by lateral flow immunoassays

Detalles Bibliográficos
Autores principales: Ebanks, Daniel, Faustini, Sian, Shields, Adrian, Parry, Helen, Moss, Paul, Plant, Tim, Richter, Alex, Drayson, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Infection Association. Published by Elsevier Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312050/
https://www.ncbi.nlm.nih.gov/pubmed/34324939
http://dx.doi.org/10.1016/j.jinf.2021.07.020
_version_ 1783729073607933952
author Ebanks, Daniel
Faustini, Sian
Shields, Adrian
Parry, Helen
Moss, Paul
Plant, Tim
Richter, Alex
Drayson, Mark
author_facet Ebanks, Daniel
Faustini, Sian
Shields, Adrian
Parry, Helen
Moss, Paul
Plant, Tim
Richter, Alex
Drayson, Mark
author_sort Ebanks, Daniel
collection PubMed
description
format Online
Article
Text
id pubmed-8312050
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The British Infection Association. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-83120502021-07-26 Cross reactivity of serological response to SARS-CoV-2 vaccination with viral variants of concern detected by lateral flow immunoassays Ebanks, Daniel Faustini, Sian Shields, Adrian Parry, Helen Moss, Paul Plant, Tim Richter, Alex Drayson, Mark J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2021-10 2021-07-26 /pmc/articles/PMC8312050/ /pubmed/34324939 http://dx.doi.org/10.1016/j.jinf.2021.07.020 Text en © 2021 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Ebanks, Daniel
Faustini, Sian
Shields, Adrian
Parry, Helen
Moss, Paul
Plant, Tim
Richter, Alex
Drayson, Mark
Cross reactivity of serological response to SARS-CoV-2 vaccination with viral variants of concern detected by lateral flow immunoassays
title Cross reactivity of serological response to SARS-CoV-2 vaccination with viral variants of concern detected by lateral flow immunoassays
title_full Cross reactivity of serological response to SARS-CoV-2 vaccination with viral variants of concern detected by lateral flow immunoassays
title_fullStr Cross reactivity of serological response to SARS-CoV-2 vaccination with viral variants of concern detected by lateral flow immunoassays
title_full_unstemmed Cross reactivity of serological response to SARS-CoV-2 vaccination with viral variants of concern detected by lateral flow immunoassays
title_short Cross reactivity of serological response to SARS-CoV-2 vaccination with viral variants of concern detected by lateral flow immunoassays
title_sort cross reactivity of serological response to sars-cov-2 vaccination with viral variants of concern detected by lateral flow immunoassays
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312050/
https://www.ncbi.nlm.nih.gov/pubmed/34324939
http://dx.doi.org/10.1016/j.jinf.2021.07.020
work_keys_str_mv AT ebanksdaniel crossreactivityofserologicalresponsetosarscov2vaccinationwithviralvariantsofconcerndetectedbylateralflowimmunoassays
AT faustinisian crossreactivityofserologicalresponsetosarscov2vaccinationwithviralvariantsofconcerndetectedbylateralflowimmunoassays
AT shieldsadrian crossreactivityofserologicalresponsetosarscov2vaccinationwithviralvariantsofconcerndetectedbylateralflowimmunoassays
AT parryhelen crossreactivityofserologicalresponsetosarscov2vaccinationwithviralvariantsofconcerndetectedbylateralflowimmunoassays
AT mosspaul crossreactivityofserologicalresponsetosarscov2vaccinationwithviralvariantsofconcerndetectedbylateralflowimmunoassays
AT planttim crossreactivityofserologicalresponsetosarscov2vaccinationwithviralvariantsofconcerndetectedbylateralflowimmunoassays
AT richteralex crossreactivityofserologicalresponsetosarscov2vaccinationwithviralvariantsofconcerndetectedbylateralflowimmunoassays
AT draysonmark crossreactivityofserologicalresponsetosarscov2vaccinationwithviralvariantsofconcerndetectedbylateralflowimmunoassays